Loading
Latest filing published 15 Jul 2022 for Marrone BIO Innovations INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Timothy B. Johnson on record concern Marrone Bio Innovations Inc, in the capacity of chief executive. Between 26 May 2021 and 12 July 2022, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 15 July 2022, the filings show a share grant in Marrone Bio Innovations Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations